1137339-95-7 Suppliers

Recommended suppliersmore

1137339-95-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1137339-95-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,7,3,3 and 9 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1137339-95:
(9*1)+(8*1)+(7*3)+(6*7)+(5*3)+(4*3)+(3*9)+(2*9)+(1*5)=157
157 % 10 = 7
So 1137339-95-7 is a valid CAS Registry Number.

1137339-95-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name	5-N-methyl-carboxamido-2-methoxy-phenyl boronic acid

1.2 Other means of identification

Product number	-
Other names	5-N-methyl-carboxamido-2-methoxy-phenylboronic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1137339-95-7 SDS

1137339-95-7Upstream product

1137339-95-7Downstream Products

1137339-95-7Relevant articles and documents

SUBSTITUTED PURINONE COMPOUNDS

-

Page/Page column 67, (2014/08/07)

The invention relates to compounds of formula (I): (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.

PYRROLOPYRROLIDINONE COMPOUNDS

-

Paragraph 0747; 0748, (2013/12/04)

The invention relates to compounds of formula (I): as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1137339-95-7

CAS

1137339-95-7